Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05570747Completed

Simulated In-House Usability Study of Eclipse Continuous Positive Airway Pressure (CPAP) Device

Role: lead

NCT05818540Not ApplicableCompleted

Sleep Apnea Study in Adults Using DreamPort-Eclipse and a Traditional Nasal Mask

Role: lead

NCT05559047Completed

Field Usability Study of Eclipse Mask

Role: lead

All 3 trials loaded